Literature DB >> 2657572

Structural characterization of the BCR gene product.

M S Timmons1, O N Witte.   

Abstract

Chronic myelogenous leukemia (CML) is associated with the reciprocal translocation of a region of chromosome 22 called BCR with the c-abl gene of chromosome 9.5' coding sequences from the BCR gene are spliced in-frame to the second exon of the ABL gene to produce a CML-specific 8.5 kilobase message which encodes the BCR-ABL hybrid protein P210. To definitively identify and characterize the normal BCR gene product, sequences from BCR cDNA clones were used to reconstitute the coding portion of the normal message in retroviral and bacterial transcription vectors. The normal BCR gene product was demonstrated to be a phosphoprotein of 160 kilodaltons by in vitro translation and immunoprecipitation from lysates of NIH3T3 lines expressing BCR retroviruses. Whereas BCR-homologous RNA levels in these cell lines were increased 50 fold, BCR protein levels increased only 2 to 10 fold depending on the presence or absence of BCR-specific 5' and 3' untranslated regions. We observe a kinase activity associated with this protein but we do not observe morphological transformation of NIH3T3 cells as a result of its overproduction.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2657572

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  10 in total

1.  The Bcr kinase downregulates Ras signaling by phosphorylating AF-6 and binding to its PDZ domain.

Authors:  G Radziwill; R A Erdmann; U Margelisch; K Moelling
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

2.  Effects of long 5' leader sequences on initiation by eukaryotic ribosomes in vitro.

Authors:  M Kozak
Journal:  Gene Expr       Date:  1991-05

Review 3.  Molecular analysis of the Philadelphia chromosome.

Authors:  A Dobrovic; G B Peters; J H Ford
Journal:  Chromosoma       Date:  1991-09       Impact factor: 4.316

Review 4.  An analysis of vertebrate mRNA sequences: intimations of translational control.

Authors:  M Kozak
Journal:  J Cell Biol       Date:  1991-11       Impact factor: 10.539

5.  Amplification of BCR protein associated with oncogenesis in human hepatocellular carcinoma.

Authors:  Y Miyazaki; T Mitsuma; T Ichida; H Odazima; K Ishihara; H Asakura
Journal:  Dig Dis Sci       Date:  1997-05       Impact factor: 3.199

6.  Common chromatin structures at breakpoint cluster regions may lead to chromosomal translocations found in chronic and acute leukemias.

Authors:  Reiner Strick; Yanming Zhang; Neelmini Emmanuel; Pamela L Strissel
Journal:  Hum Genet       Date:  2006-03-30       Impact factor: 4.132

7.  A limited set of SH2 domains binds BCR through a high-affinity phosphotyrosine-independent interaction.

Authors:  A J Muller; A M Pendergast; M H Havlik; L Puil; T Pawson; O N Witte
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

8.  Tyrosine phosphorylation of BCR by FPS/FES protein-tyrosine kinases induces association of BCR with GRB-2/SOS.

Authors:  Y Maru; K L Peters; D E Afar; M Shibuya; O N Witte; T E Smithgall
Journal:  Mol Cell Biol       Date:  1995-02       Impact factor: 4.272

9.  Bcr and Raf form a complex in vivo via 14-3-3 proteins.

Authors:  S Braselmann; F McCormick
Journal:  EMBO J       Date:  1995-10-02       Impact factor: 11.598

Review 10.  Chibby 1: a new component of β-catenin-signaling in chronic myeloid leukemia.

Authors:  Manuela Mancini; Simona Soverini; Gabriele Gugliotta; Maria Alessandra Santucci; Gianantonio Rosti; Michele Cavo; Giovanni Martinelli; Fausto Castagnetti
Journal:  Oncotarget       Date:  2017-09-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.